摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

Cyclohepten-(4)-yl-(1)-acetat | 82706-18-1

中文名称
——
中文别名
——
英文名称
Cyclohepten-(4)-yl-(1)-acetat
英文别名
4-Cyclohepten-1-yl acetate;cyclohept-4-en-1-yl acetate
Cyclohepten-(4)-yl-(1)-acetat化学式
CAS
82706-18-1
化学式
C9H14O2
mdl
——
分子量
154.209
InChiKey
JYKJRDZRIBJUAL-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    198.5±29.0 °C(Predicted)
  • 密度:
    0.98±0.1 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    2
  • 重原子数:
    11
  • 可旋转键数:
    2
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.67
  • 拓扑面积:
    26.3
  • 氢给体数:
    0
  • 氢受体数:
    2

反应信息

  • 作为反应物:
    参考文献:
    名称:
    Proximity Effects. XXIX. Solvolysis of Cycloheptenyl Derivatives
    摘要:
    DOI:
    10.1021/ja00883a045
  • 作为产物:
    描述:
    环庚烯溶剂黄146 在 palladium diacetate 、 甲烷磺酸对苯醌 作用下, 反应 23.0h, 生成 3-Cycloheptenyl-acetatCyclohepten-(4)-yl-(1)-acetat
    参考文献:
    名称:
    钯催化的烯丙基乙酰氧基化:添加酸影响的探索性研究
    摘要:
    为了研究提高取代的环烯烃和直链烯烃在钯催化的乙酰氧基化反应中的选择性的可能性,研究了添加强酸的影响。发现在某些情况下可以提高产物的选择性,但是当使用三氟乙酸或强酸时,副反应也会降低总产率。选择性的提高可能是由于乙酰氧基化机理的改变。
    DOI:
    10.1016/0022-328x(89)85192-7
点击查看最新优质反应信息

文献信息

  • NOVEL POLYMER AND PROCESS FOR PRODUCING THE SAME
    申请人:KURARAY CO., LTD.
    公开号:EP1598384A1
    公开(公告)日:2005-11-23
    A polymer consisting mainly of structural units represented by the general formula (1), wherein the total molar amount of terminal aldehyde groups and acetal groups is 0.6 mol% or smaller based on the total molar amount of the structural units represented by the general formula (1). -[-(-CHR1-)n-CX1R2-CX2R3-]-(1) (In the formula, n is an integer of 2 to 10; X1 and X2 each represents -H, -OH, or a functional group capable of being converted into -OH, provided that at least one of X1 and X2 is hydroxy or a functional group capable of being converted into hydroxy; and R1, R2 and R3 each represents -H or C1-5 alkyl, aryl, aralkyl, or heteroaryl and the two or more R1's may be different).
    一种主要由通式(1)所代表的结构单元组成的聚合物,其中末端醛基和缩醛基的摩尔总量占通式(1)所代表的结构单元摩尔总量的 0.6 摩尔%或更小。-[-(-CHR1-)n-CX1R2-CX2R3-]-(1) (式中,n 为 2-10 的整数;X1 和 X2 各自代表-H、-OH 或可转化为-OH 的官能团,条件是 X1 和 X2 中至少有一个是羟基或可转化为羟基的官能团;R1、R2 和 R3 各自代表-H 或 C1-5 烷基、芳基、芳烷基或杂芳基,两个或多个 R1 可以不同)。
  • PROCESS FOR PRODUCING RING-OPENING METATHESIS POLYMER
    申请人:KURARAY CO., LTD.
    公开号:EP1847558A1
    公开(公告)日:2007-10-24
    The process of producing a ring-opening metathesis polymer of the present invention is mainly characterized in that a treatment to decrease the amount of oxygen and/or peroxide in at least one kind of polymerization starting material is performed prior to the ring-opening metathesis polymerization reaction of a cyclic olefin performed in the presence of a ruthenium carbene complex (catalyst). As used herein, the "polymerization starting material" refers to various materials used for a ring-opening metathesis polymerization reaction and present in the reaction system, such as ruthenium carbene complex (catalyst) and cyclic olefin (monomer), as well as solvents, chain transfer agents and the like. In addition, the method for a treatment to decrease the amount of oxygen and/or peroxide include a method comprising applying an adsorbent to a polymerization starting material to remove oxygen and/or peroxide by adsorption, a method comprising applying an antioxidant to a polymerization starting material to decompose oxygen or peroxide and the like. According to the present invention, a ring-opening metathesis polymer can be produced at a higher reaction rate without degrading the high activity inherently possessed by a' ruthenium carbene complex (catalyst). Because of being free of a decrease in the concentration of the catalyst maintaining the high activity during reaction, the thus-obtained polymer shows a small difference between polymerization lots and becomes homogeneous, and a polymer having a comparatively sharp molecular weight distribution can be produced.
    本发明的开环偏聚聚合物生产工艺的主要特点是,在碳化钌络合物(催化剂)存在下进行环烯烃的开环偏聚聚合反应之前,先进行处理以减少至少一种聚合起始材料中的氧和/或过氧化物的含量。本文所用的 "聚合起始材料 "是指用于开环偏聚聚合反应并存在于反应体系中的各种材料,例如碳化钌络合物(催化剂)和环烯烃(单体),以及溶剂、链转移剂等。此外,减少氧气和/或过氧化物量的处理方法还包括将吸附剂应用于聚合起始材料以通过吸附去除氧气和/或过氧化物的方法、将抗氧化剂应用于聚合起始材料以分解氧气或过氧化物的方法等。 根据本发明,可以在不降低'碳化钌络合物(催化剂)固有的高活性的情况下,以更高的反应速率生产开环偏聚聚合物。由于在反应过程中保持高活性的催化剂浓度不会降低,因此得到的聚合物在聚合批次之间的差异很小,而且变得均匀,并能生产出分子量分布比较均匀的聚合物。
  • PROCESS FOR PRODUCTION OF HYDROGENATED POLYMERS AND HYDROGENATED POLYMERS
    申请人:Kuraray Co., Ltd.
    公开号:EP2070964A1
    公开(公告)日:2009-06-17
    Provision of, in a process of producing a hydrogenated polymer, which comprises steps of sequentially performing, in the presence of a ruthenium carbene complex, a ring-opening metathesis polymerization reaction of a cyclic olefin and a hydrogenation reaction of a ring-opening metathesis polymer produced by the polymerization reaction to give a hydrogenated polymer, a simple and economic process of obtaining a hydrogenated polymer having an extremely small content of residual ruthenium derived from the ruthenium carbene complex. A process of producing a hydrogenated polymer, which comprises, in the presence of a ruthenium carbene complex, subjecting a cyclic monoolefin and/or a cyclic diolefin to a ring-opening metathesis polymerization, hydrogenating the resulting ring-opening metathesis polymer to give a hydrogenated polymer, and bringing the hydrogenated polymer in contact with a poor solvent of the hydrogenated polymer in the presence of dissolved hydrogen to allow precipitation. As the poor solvent of the hydrogenated polymer, alcohol having 1 to 6 carbon atoms, ketone having 3 to 6 carbon atoms and the like are preferable.
    在一种生产氢化聚合物的工艺中,包括以下步骤:在有碳化钌络合物存在的情况下,依次进行环状烯烃的开环偏聚聚合反应和由聚合反应生成的开环偏聚聚合物的氢化反应,以得到氢化聚合物。 一种氢化聚合物的生产工艺,它包括在碳化钌络合物存在的情况下,使环状单烯烃和/或环状二烯烃进行开环偏聚聚合反应,将得到的开环偏聚聚合体氢化,得到氢化聚合物,并使氢化聚合物在溶解氢存在的情况下与氢化聚合物的贫溶剂接触,使其沉淀。作为氢化聚合物的贫溶剂,最好是 1 至 6 个碳原子的醇、3 至 6 个碳原子的酮等。
  • Novel polymer and process for producing the same
    申请人:Arimoto Kikuo
    公开号:US20060149009A1
    公开(公告)日:2006-07-06
    A polymer consisting mainly of structural units represented by the general formula (1), wherein the total molar amount of terminal aldehyde groups and acetal groups is 0.6 mol % or smaller based on the total molar amount of the structural units represented by the general formula (1). —[—(—CHR 1 —) n —CX 1 R 2 —CX 2 R 3 -]— (1) (In the formula, n is an integer of 2 to 10; X 1 and X 2 each represents —H, —OH, or a functional group capable of being converted into —OH, provided that at least one of X 1 and X 2 is hydroxy or a functional group capable of being converted into hydroxy; and R 1 , R 2 , and R 3 each represents —H or C 1-5 alkyl, aryl, aralkyl, or heteroaryl and the two or more R 1 's may be different.)
    一种主要由通式(1)所代表的结构单元组成的聚合物,其中末端醛基和缩醛基的摩尔总量占通式(1)所代表的结构单元摩尔总量的 0.6 摩尔%或更小。-[-(-CHR 1 -) n -CX 1 R 2 -CX 2 R 3 -]-(1)(式中,n 为 2 至 10 的整数;X 1 和 X 2 各自代表-H、-OH 或可转化为-OH 的官能团,条件是 X 1 和 X 2 是羟基或可转化为羟基的官能团;以及 R 1 , R 2 和 R 3 各自代表-H 或 C 1-5 烷基、芳基、芳烷基或杂芳基,而两个或多个 R 1 可以不同)。
  • Harayama, Takashi; Fukushi, Hideto; Ogawa, Kazuhiro, Chemical and pharmaceutical bulletin, 1985, vol. 33, # 8, p. 3564 - 3566
    作者:Harayama, Takashi、Fukushi, Hideto、Ogawa, Kazuhiro、Yoneda, Fumio
    DOI:——
    日期:——
查看更多

同类化合物

(甲基3-(二甲基氨基)-2-苯基-2H-azirene-2-羧酸乙酯) (±)-盐酸氯吡格雷 (±)-丙酰肉碱氯化物 (d(CH2)51,Tyr(Me)2,Arg8)-血管加压素 (S)-(+)-α-氨基-4-羧基-2-甲基苯乙酸 (S)-阿拉考特盐酸盐 (S)-赖诺普利-d5钠 (S)-2-氨基-5-氧代己酸,氢溴酸盐 (S)-2-[3-[(1R,2R)-2-(二丙基氨基)环己基]硫脲基]-N-异丙基-3,3-二甲基丁酰胺 (S)-1-(4-氨基氧基乙酰胺基苄基)乙二胺四乙酸 (S)-1-[N-[3-苯基-1-[(苯基甲氧基)羰基]丙基]-L-丙氨酰基]-L-脯氨酸 (R)-乙基N-甲酰基-N-(1-苯乙基)甘氨酸 (R)-丙酰肉碱-d3氯化物 (R)-4-N-Cbz-哌嗪-2-甲酸甲酯 (R)-3-氨基-2-苄基丙酸盐酸盐 (R)-1-(3-溴-2-甲基-1-氧丙基)-L-脯氨酸 (N-[(苄氧基)羰基]丙氨酰-N〜5〜-(diaminomethylidene)鸟氨酸) (6-氯-2-吲哚基甲基)乙酰氨基丙二酸二乙酯 (4R)-N-亚硝基噻唑烷-4-羧酸 (3R)-1-噻-4-氮杂螺[4.4]壬烷-3-羧酸 (3-硝基-1H-1,2,4-三唑-1-基)乙酸乙酯 (2S,3S,5S)-2-氨基-3-羟基-1,6-二苯己烷-5-N-氨基甲酰基-L-缬氨酸 (2S,3S)-3-((S)-1-((1-(4-氟苯基)-1H-1,2,3-三唑-4-基)-甲基氨基)-1-氧-3-(噻唑-4-基)丙-2-基氨基甲酰基)-环氧乙烷-2-羧酸 (2S)-2,6-二氨基-N-[4-(5-氟-1,3-苯并噻唑-2-基)-2-甲基苯基]己酰胺二盐酸盐 (2S)-2-氨基-3-甲基-N-2-吡啶基丁酰胺 (2S)-2-氨基-3,3-二甲基-N-(苯基甲基)丁酰胺, (2S,4R)-1-((S)-2-氨基-3,3-二甲基丁酰基)-4-羟基-N-(4-(4-甲基噻唑-5-基)苄基)吡咯烷-2-甲酰胺盐酸盐 (2R,3'S)苯那普利叔丁基酯d5 (2R)-2-氨基-3,3-二甲基-N-(苯甲基)丁酰胺 (2-氯丙烯基)草酰氯 (1S,3S,5S)-2-Boc-2-氮杂双环[3.1.0]己烷-3-羧酸 (1R,4R,5S,6R)-4-氨基-2-氧杂双环[3.1.0]己烷-4,6-二羧酸 齐特巴坦 齐德巴坦钠盐 齐墩果-12-烯-28-酸,2,3-二羟基-,苯基甲基酯,(2a,3a)- 齐墩果-12-烯-28-酸,2,3-二羟基-,羧基甲基酯,(2a,3b)-(9CI) 黄酮-8-乙酸二甲氨基乙基酯 黄荧菌素 黄体生成激素释放激素 (1-5) 酰肼 黄体瑞林 麦醇溶蛋白 麦角硫因 麦芽聚糖六乙酸酯 麦根酸 麦撒奎 鹅膏氨酸 鹅膏氨酸 鸦胆子酸A甲酯 鸦胆子酸A 鸟氨酸缩合物